APA (7th ed.) Citation

Barbosa, B. L. F., Freitas, T. R., Almeida, M. d. O., Araújo, S. S. d. S., Andrade, A. C., Dornelas, G. G., . . . Sabino, A. d. P. (2021). Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Future pharmacology, 1(1), 60-79. https://doi.org/10.3390/futurepharmacol1010006

Chicago Style (17th ed.) Citation

Barbosa, Bárbara Lima Fonseca, Tulio Resende Freitas, Michell de Oliveira Almeida, Sérgio Schusterschitz da Silva Araújo, Ana Clara Andrade, Geovana Gomes Dornelas, Julyana Gayva Fiorotto, Vinicius Gonçalves Maltarollo, and Adriano de Paula Sabino. "Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia." Future Pharmacology 1, no. 1 (2021): 60-79. https://doi.org/10.3390/futurepharmacol1010006.

MLA (9th ed.) Citation

Barbosa, Bárbara Lima Fonseca, et al. "Virtual Screening of Adenylate Kinase 3 Inhibitors Employing Pharmacophoric Model, Molecular Docking, and Molecular Dynamics Simulations as Potential Therapeutic Target in Chronic Lymphocytic Leukemia." Future Pharmacology, vol. 1, no. 1, 2021, pp. 60-79, https://doi.org/10.3390/futurepharmacol1010006.